Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma

CONCLUSIONS: TMZ-based SDT was capable of triggering ICD in glioma. The discovery of TMZ as a sonosensitizer have shown great promise in the treatment of GBM.PMID:37716612 | DOI:10.1016/j.clim.2023.109772

Source: Clinical Immunology - September 16, 2023 Category: Allergy & Immunology Authors: Yan Zhou Jiji Jiao Rongyan Yang Binli Wen Qiaoli Wu Lixia Xu Xiaoguang Tong Hua Yan Source Type: research